BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22061836)

  • 1. Prostaglandin E2 receptor expression in the rat trigeminal-vascular system and other brain structures involved in pain.
    Myren M; Olesen J; Gupta S
    Neurosci Lett; 2012 Jan; 506(1):64-9. PubMed ID: 22061836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase (NOS) in the trigeminal vascular system and other brain structures related to pain in rats.
    Ramachandran R; Ploug KB; Hay-Schmidt A; Olesen J; Jansen-Olesen I; Gupta S
    Neurosci Lett; 2010 Nov; 484(3):192-6. PubMed ID: 20736047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system.
    Kruse LS; Møller M; Tibaek M; Gammeltoft S; Olesen J; Kruuse C
    Brain Res; 2009 Jul; 1281():25-34. PubMed ID: 19445908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system.
    Kruse LS; Sandholdt NT; Gammeltoft S; Olesen J; Kruuse C
    Neurosci Lett; 2006 Aug; 404(1-2):202-7. PubMed ID: 16808996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cells isolated from dorsal root ganglia express prostaglandin E(2) (EP(4)) and prostacyclin (IP) receptors.
    Ng KY; Wong YH; Wise H
    Eur J Pharmacol; 2011 Jul; 661(1-3):42-8. PubMed ID: 21549696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain.
    Ohishi H; Akazawa C; Shigemoto R; Nakanishi S; Mizuno N
    J Comp Neurol; 1995 Oct; 360(4):555-70. PubMed ID: 8801249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors.
    Zhu P; Genc A; Zhang X; Zhang J; Bazan NG; Chen C
    J Neurosci Res; 2005 Sep; 81(6):817-26. PubMed ID: 16041798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP3 and EP4 receptor mRNA expression in peptidergic cell groups of the rat parabrachial nucleus.
    Engblom D; Ek M; Ericsson-Dahlstrand A; Blomqvist A
    Neuroscience; 2004; 126(4):989-99. PubMed ID: 15207332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
    Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
    Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC.
    Bhatt DK; Gupta S; Ploug KB; Jansen-Olesen I; Olesen J
    Neurosci Lett; 2014 Jan; 559():99-104. PubMed ID: 24321404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine.
    Myren M; Baun M; Ploug KB; Jansen-Olesen I; Olesen J; Gupta S
    Cephalalgia; 2010 Sep; 30(9):1110-22. PubMed ID: 20713561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of P2X3 receptor in the trigeminal sensory nuclei of the rat.
    Kim YS; Paik SK; Cho YS; Shin HS; Bae JY; Moritani M; Yoshida A; Ahn DK; Valtschanoff J; Hwang SJ; Moon C; Bae YC
    J Comp Neurol; 2008 Feb; 506(4):627-39. PubMed ID: 18067147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins in migraine: update.
    Antonova M; Wienecke T; Olesen J; Ashina M
    Curr Opin Neurol; 2013 Jun; 26(3):269-75. PubMed ID: 23519238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
    Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
    J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of chicken prostaglandin E receptor subtypes 2 and 4 (EP2 and EP4).
    Kwok AH; Wang Y; Wang CY; Leung FC
    Gen Comp Endocrinol; 2008 Jun; 157(2):99-106. PubMed ID: 18486942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptors.
    Warfvinge K; Krause DN; Maddahi A; Grell AS; Edvinsson JC; Haanes KA; Edvinsson L
    Cephalalgia; 2020 Oct; 40(12):1283-1295. PubMed ID: 32486908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and expression profile of the prostaglandin I(2) receptor in the rat craniovascular system.
    Myren M; Olesen J; Gupta S
    Vascul Pharmacol; 2011; 55(1-3):50-8. PubMed ID: 21749934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cephalic upregulation of p-ERK, CamKII and p-CREB in response to glyceryl trinitrate infusion.
    Ramachandran R; Pedersen SH; Amrutkar DV; Petersen S; Jacobsen JM; Hay-Schmidt A; Olesen J; Jansen-Olesen I
    Cephalalgia; 2018 May; 38(6):1057-1070. PubMed ID: 28738691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of PGD
    Sekeroglu A; Jacobsen JM; Jansen-Olesen I; Gupta S; Sheykhzade M; Olesen J; Bhatt DK
    Pharmacol Rep; 2017 Feb; 69(1):50-56. PubMed ID: 27898338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.